Literature DB >> 19433660

Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.

Alexandra Seewann1, Hugo Vrenken, Paul van der Valk, Erwin L A Blezer, Dirk L Knol, Jonas A Castelijns, C H Polman, Petra J W Pouwels, Frederik Barkhof, Jeroen J G Geurts.   

Abstract

BACKGROUND: Diffuse abnormalities in the white matter (WM), ie, the so-called diffusely abnormal WM (DAWM), as observed on magnetic resonance imaging (MRI), may contribute to the development of clinical disability in multiple sclerosis (MS). Underlying pathologic and MRI characteristics of DAWM are largely unknown.
OBJECTIVES: To explore and describe the histopathologic and radiologic characteristics of DAWM in chronic MS.
DESIGN: An MRI and histopathologic postmortem correlative study.
METHODS: We analyzed 17 formalin-fixed hemispheric brain slices from 10 patients with chronic MS using histopathologic analysis and qualitative and quantitative MRI. A region-of-interest approach was applied to compare radiologically defined DAWM, normal-appearing WM, and focal WM lesions and to correlate quantitative MRI measures with histopathologic findings. MAIN OUTCOME MEASURES: The DAWM consisted of extensive axonal loss, decreased myelin density, and chronic fibrillary gliosis, all of which were substantially abnormal compared with normal-appearing WM and significantly different from focal WM lesion pathology. Increased T1- and T2-relaxation times and decreased fractional anisotropy values were found in DAWM regions of interest, in association with extensive axonal loss and reduced myelin density. Increased T1- and T2-relaxation times were associated with chronic gliosis.
CONCLUSIONS: This study classifies DAWM in chronic MS as an abnormality that is different from normal-appearing WM and focal WM lesions, most likely resulting from the cumulative effects of ongoing inflammation and axonal pathology. As such, DAWM is likely to substantially contribute to disease progression and may prove to be an important new disease marker in clinical trials focusing on the neurodegenerative aspects of MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433660     DOI: 10.1001/archneurol.2009.57

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  58 in total

1.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy.

Authors:  J P van der Voorn; P J W Pouwels; J M Powers; W Kamphorst; J-J Martin; D Troost; M D Spreeuwenberg; F Barkhof; M S van der Knaap
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

Review 3.  Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

Authors:  Christian Enzinger; Frederik Barkhof; Olga Ciccarelli; Massimo Filippi; Ludwig Kappos; Maria A Rocca; Stefan Ropele; Àlex Rovira; Torben Schneider; Nicola de Stefano; Hugo Vrenken; Claudia Wheeler-Kingshott; Jens Wuerfel; Franz Fazekas
Journal:  Nat Rev Neurol       Date:  2015-11-03       Impact factor: 42.937

4.  Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.

Authors:  Jean Shin; Celine Bourdon; Manon Bernard; Michael D Wilson; Eva Reischl; Melanie Waldenberger; Barbara Ruggeri; Gunter Schumann; Sylvane Desrivieres; Alexander Leemans; Michal Abrahamowicz; Gabriel Leonard; Louis Richer; Luigi Bouchard; Daniel Gaudet; Tomas Paus; Zdenka Pausova
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

5.  In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.

Authors:  Pascal Sati; Anne H Cross; Jie Luo; Charles F Hildebolt; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2010-03-23       Impact factor: 6.556

6.  Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.

Authors:  H Vrenken; A Seewann; D L Knol; C H Polman; F Barkhof; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

7.  Dirty-appearing white matter: a disregarded entity in multiple sclerosis.

Authors:  M Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

Review 8.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

9.  Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.

Authors:  Biao Xiang; Jie Wen; Anne H Cross; Dmitriy A Yablonskiy
Journal:  J Magn Reson Imaging       Date:  2018-08-29       Impact factor: 4.813

10.  Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Authors:  Lutz Achtnichts; Oded Gonen; Daniel J Rigotti; James S Babb; Yvonne Naegelin; Iris-Katharina Penner; Kerstin Bendfeldt; Jochen Hirsch; Michael Amann; Ludwig Kappos; Achim Gass
Journal:  Eur J Radiol       Date:  2013-09-04       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.